/SKIN
SKIN Stock - The Beauty Health Company
Consumer Defensive|Household & Personal ProductsNASDAQ
$1.53+0.00%
+$0.00 (+0.00%) • Dec 19
74
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.BUY
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.57
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).100
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.73
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+35.9%upside
Target: $2.08
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for SKIN
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$1.51 – $1.55
TARGET (TP)$2.08
STOP LOSS$1.41
RISK/REWARD1:4.6
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta1.18
52W High$2.69
52W Low$0.78
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $334.29M | $397.99M | $365.88M | $260.09M | $119.09M |
| Gross Profit | $182.30M | $155.11M | $248.78M | $178.54M | $67.20M |
| Gross Margin | 54.5% | 39.0% | 68.0% | 68.6% | 56.4% |
| Operating Income | $-67,774,000 | $-130,917,000 | $-25,841,000 | $-39,928,000 | $-17,182,000 |
| Net Income | $-29,098,000 | $-100,116,000 | $44.22M | $-378,764,000 | $-29,175,000 |
| Net Margin | -8.7% | -25.2% | 12.1% | -145.6% | -24.5% |
| EPS | $-0.23 | $-0.76 | $0.30 | $-3.67 | $-0.85 |
Company Overview
The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, peel, exfoliate, extract, infuse, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a HydraFacial Delivery System designed to elevate every part of the treatment and connects providers to the consumer's preferences to create a more personalized experience; HydraFacial Nation App, an app that allows consumers to learn about their skin health, discover treatment options, and track their treatments over time; and Keravive, a treatment for scalp health. The company was founded in 1997 and is headquartered in Long Beach, California.
Visit WebsiteRating Distribution
Strong Buy
0%
Buy / Outperform
2
22%
Hold / Neutral
6
67%
Sell / Underperform
1
11%
Analyst Consensus🔴 Bearish
2 Bullish7 Neutral/Bearish
Price Targets
$5
Average Target
↑ 251.3% Upside
Now
$2
Low
$5
Average
$11
High
Based on 8 analysts
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| September 19th 2025 | Roth Capital | Initiation | Buy | $3.5 |
| November 15th 2023 | Jefferies | Downgrade | Hold | $1.5← $11 |
| November 14th 2023 | JP Morgan | Downgrade | Underweight | - |
| November 14th 2023 | Canaccord Genuity | Downgrade | Hold | $2.5← $10 |
| November 14th 2023 | Piper Sandler | Downgrade | Underweight | $2← $12 |
| November 14th 2023 | TD Cowen | Downgrade | Market Perform | $2.5← $9 |
| November 14th 2023 | The Benchmark Company | Downgrade | Hold | - |
| November 14th 2023 | Raymond James | Downgrade | Underperform | - |
| November 14th 2023 | William Blair | Downgrade | Market Perform | - |
| August 25th 2023 | Canaccord Genuity | Resumed | Buy | $10 |
| June 21st 2023 | Stifel | Downgrade | Hold | $10← $17 |
| March 20th 2023 | Exane BNP Paribas | Upgrade | Neutral | - |
| November 9th 2022 | JP Morgan | Downgrade | Neutral | $11← $22 |
Earnings History & Surprises
SKINBeat Rate
67%
Last 15 quarters
Avg Surprise
+1132.2%
EPS vs Estimate
Beats / Misses
10/4
1 met exactly
Latest EPS
$-0.09
Q4 2025
EPS Surprise History
Q1 24
+36.4%
$-0.07vs$-0.11
Q2 24
+28.6%
$-0.10vs$-0.14
Q3 24
-100.0%
$-0.10vs$-0.05
Q4 24
-25.0%
$-0.15vs$-0.12
Q1 25
+20.0%
$-0.08vs$-0.10
Q2 25
+38.5%
$-0.08vs$-0.13
Q3 25
+150.0%
$0.03vs$-0.06
Q4 25
-12.5%
$-0.09vs$-0.08
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 6, 2026 | — | — | — | — |
Q1 2026 | Mar 11, 2026 | $-0.06 | — | — | — |
Q4 2025 | Nov 6, 2025 | $-0.08 | $-0.09 | -12.5% | ✗ MISS |
Q3 2025 | Aug 7, 2025 | $-0.06 | $0.03 | +150.0% | ✓ BEAT |
Q2 2025 | May 8, 2025 | $-0.13 | $-0.08 | +38.5% | ✓ BEAT |
Q1 2025 | Mar 12, 2025 | $-0.10 | $-0.08 | +20.0% | ✓ BEAT |
Q4 2024 | Nov 12, 2024 | $-0.12 | $-0.15 | -25.0% | ✗ MISS |
Q3 2024 | Aug 8, 2024 | $-0.05 | $-0.10 | -100.0% | ✗ MISS |
Q2 2024 | May 9, 2024 | $-0.14 | $-0.10 | +28.6% | ✓ BEAT |
Q1 2024 | Mar 12, 2024 | $-0.11 | $-0.07 | +36.4% | ✓ BEAT |
Q4 2023 | Nov 13, 2023 | $0.04 | $0.05 | +17.6% | ✓ BEAT |
Q3 2023 | Aug 9, 2023 | $0.05 | $0.07 | +40.0% | ✓ BEAT |
Q2 2023 | May 10, 2023 | $-0.02 | $-0.04 | -80.0% | ✗ MISS |
Q1 2023 | Feb 28, 2023 | $0.06 | $0.06 | 0.0% | = MET |
Q4 2022 | Dec 15, 2022 | — | $0.21 | — | — |
Q4 2022 | Dec 15, 2022 | — | $0.04 | — | — |
Q4 2022 | Dec 15, 2022 | — | $-0.12 | — | — |
Q4 2022 | Nov 8, 2022 | $0.01 | $0.02 | +164.6% | ✓ BEAT |
Q4 2021 | Nov 9, 2021 | $-0.00 | $0.01 | +11211.1% | ✓ BEAT |
Q3 2021 | Aug 10, 2021 | $0.00 | $0.08 | +5494.4% | ✓ BEAT |
Latest News
The Beauty Health Company Option Alert: Dec 19 $1.5 Calls Sweep (52) near the Ask: 1960 @ $0.151 vs 436 OI; Ref=$1.315
📈 PositiveBenzinga•Nov 21, 2025, 03:57 PM
The Beauty Health shares are trading higher after the company reported better-than-expected Q3 sales results and raised its FY25 sales guidance with its midpoint above estimates.
📈 PositiveBenzinga•Nov 7, 2025, 12:17 PM
The Beauty Health shares are trading higher after the company reported better-than-expected Q3 sales results and raised its FY25 sales guidance with its midpoint above estimates.
📈 PositiveBenzinga•Nov 6, 2025, 10:06 PM
Beauty Health Raises FY2025 Sales Guidance from $285.000M-$300.000M to $293.000M-$300.000M vs $293.822M Est
➖ NeutralBenzinga•Nov 6, 2025, 09:29 PM
Beauty Health Q3 EPS $(0.09) Misses $(0.07) Estimate, Sales $70.700M Beat $68.592M Estimate
➖ NeutralBenzinga•Nov 6, 2025, 09:27 PM
The Beauty Health Company Appoints Pedro Malha As President And CEO Effective Oct. 1; Succeeds Marla Beck
➖ NeutralBenzinga•Sep 30, 2025, 08:31 PM
TD Cowen Maintains Hold on Beauty Health, Raises Price Target to $2.5
➖ NeutralBenzinga•Sep 22, 2025, 01:34 PM
Roth Capital Initiates Coverage On Beauty Health with Buy Rating, Announces Price Target of $3.5
📈 PositiveBenzinga•Sep 19, 2025, 05:52 PM
The Beauty Health GAAP EPS of -$0.08 beats by $0.05, revenue of $69.6M beats by $6.5M
📈 PositiveSeeking Alpha•May 8, 2025, 09:20 PM
Frequently Asked Questions about SKIN
What is SKIN's current stock price?
The Beauty Health Company (SKIN) is currently trading at $1.53 per share. The stock has moved +0.00% today.
What is the analyst price target for SKIN?
The average analyst price target for SKIN is $2.08, based on 1 analyst.
What sector is The Beauty Health Company in?
The Beauty Health Company operates in the Consumer Defensive sector, specifically within the Household & Personal Products industry. The company is traded on the NASDAQ exchange.
What is SKIN's market cap?
The Beauty Health Company has a market capitalization of $0.20 billion, making it a small-cap company.
Does SKIN pay dividends?
No, The Beauty Health Company does not currently pay a dividend to shareholders.
Similar Stocks
Consumer Defensive SectorABVE
Above Food Ingredients Inc. Common Stock
$1.69
Mkt Cap: $0.1B
ACU
Acme United Corporation
$42.37
Mkt Cap: $0.2B
EPSM
Epsium Enterprise Limited Ordinary Shares
$2.35
Mkt Cap: $0.0B
EWCZ
European Wax Center, Inc.
$3.62
Mkt Cap: $0.2B
FTLF
FitLife Brands, Inc.
$16.88
Mkt Cap: $0.2B
PTNM
Pitanium Limited
$10.39
Mkt Cap: $0.2B
SKIL
Skillsoft Corp.
$7.74
Mkt Cap: $0.1B
SLSN
Solesence, Inc. Common Stock
$2.04
Mkt Cap: $0.1B
YOUL
Youlife Group Inc. American Depositary Shares
$1.56
Mkt Cap: $0.1B
ZVIA
Zevia PBC
$2.62
Mkt Cap: $0.2B
Explore stocks similar to SKIN for comparison